The University of Alabama at Birmingham Comprehensive Cancer Center — Birmingham, Alabama

The University of Alabama at Birmingham Comprehensive Cancer Center is a clinical research site located in Birmingham, Alabama, United States 35294.

Crixeo Health Trust Score: 63/100 (FAIR). This profile has not yet been claimed by the site owner.

The University of Alabama at Birmingham Comprehensive Cancer Center has participated in 2 clinical trials.

Therapeutic areas: Breast Cancer, Epstein-Barr Virus Associated Lymphoma, EBV-Positive DLBCL, NOS.

Sponsors: Celldex Therapeutics, Viracta Therapeutics, Inc..

Sponsor Feasibility Report

Trust Score: 63/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for The University of Alabama at Birmingham Comprehensive Cancer Center?

The University of Alabama at Birmingham Comprehensive Cancer Center has a Crixeo Trust Score of 63/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has The University of Alabama at Birmingham Comprehensive Cancer Center conducted?

The University of Alabama at Birmingham Comprehensive Cancer Center has 2 clinical trials on record. Their work covers Breast Cancer, Epstein-Barr Virus Associated Lymphoma, EBV-Positive DLBCL, NOS.

Is The University of Alabama at Birmingham Comprehensive Cancer Center accredited by Crixeo Health?

The University of Alabama at Birmingham Comprehensive Cancer Center has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about The University of Alabama at Birmingham Comprehensive Cancer Center?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.